Los pacientes con COVID negros e hispanos tienen menos probabilidades de que les den el antiviral Paxlovid
VIERNES, 28 de octubre de 2022 (HealthDay News) — Los pacientes negros e hispanos son menos propensos a que les administren medicamentos antivirales, como Paxlovid, para ayudar a luchar contra la COVID-19, que los pacientes blancos, muestra un nuevo …
Learn MoreTreated or Untreated, COVID Symptoms Can Ease and Then Return, Study Finds
MONDAY, Oct. 31, 2022 (HealthDay News) — Nearly everyone has heard of Paxlovid rebound, where COVID-19 symptoms return after taking the antiviral and then feeling better. It even happened to President Joe Biden. But new research shows it also happens…
Learn MoreHearts From Donors Who Had COVID Are Safe for Transplant
MONDAY, Oct. 31, 2022 (HealthDay News) — A person with heart failure in dire need of a new heart may have faced delays in getting one during the pandemic when potential donors tested positive for COVID-19. As some centers began accepting these hearts…
Learn MoreLong COVID Prevalent in U.S. Adults With Prior COVID-19 Infection
FRIDAY, Oct. 28, 2022 (HealthDay News) — Nearly 15 percent of U.S. adults with a prior positive COVID-19 test reported current symptoms of long COVID, according to a study published online Oct. 27 in JAMA Network Open.Roy H. Perlis, M.D., from Massac…
Learn MoreOmicron BA.2 Subvariant Less Severe Than Delta, Original Omicron
FRIDAY, Oct. 28, 2022 (HealthDay News) — The omicron BA.2 subvariant seems to be less severe than the delta variant and the original omicron variant, according to a study published online Oct. 25 in JAMA Network Open.Zachary H. Strasser, M.D., from M…
Learn MoreBlack, Hispanic COVID Patients Less Likely to Get Antiviral Paxlovid
FRIDAY, Oct. 28, 2022 (HealthDay News) — Black and Hispanic patients are less likely to be given antiviral drugs such as Paxlovid to help battle a bout of COVID-19 than white patients are, a new government report shows.In a study of more than 700,000…
Learn MoreDisparities ID’d in Dispensing of Oral Antivirals for COVID-19
THURSDAY, Oct. 27, 2022 (HealthDay News) — Disparities are seen in the dispensing of oral antiviral drugs for treatment of COVID-19 based on social vulnerability zip codes, according to research published in the Oct. 28 issue of the U.S. Centers for…
Learn MoreLanzan en China una vacuna contra la COVID que se inhala por la boca
MIÉRCOLES, 26 de octubre de 2022 (HealthDay News) — El miércoles, China anunció que comenzó a administrar a sus ciudadanos un refuerzo contra la COVID que se puede inhalar a través de la bocaLa vacuna oral se distribuyó en Shanghái. Apareció un video…
Learn MorePooled Risk for Thrombocytopenia Increased After ChAdOx1-S Vaccine
THURSDAY, Oct. 27, 2022 (HealthDay News) — The risk for thrombocytopenia is increased after receipt of the ChAdOx1-S vaccine compared with BNT162b2, according to a study published online Oct. 26 in The BMJ.Xintong Li, from the University of Oxford in…
Learn MoreOverall Symptoms After BNT162b2, Other Vaccines Comparable in <5s
THURSDAY, Oct. 27, 2022 (HealthDay News) — Among children younger than 5 years, guardian-reported symptoms after BNT162b2 administration were generally comparable to those for on-label non-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Learn More